Announced
Completed
Synopsis
Ally Bridge Group, a global healthcare investment management firm, led a $50m funding round in Ceribell, a medical device start-up company. "We are excited to partner with Ally Bridge and appreciate the continued support from our existing shareholders. Based on our progress to date, it is clear that the Ceribell Rapid EEG system is improving the quality of care seizure patients receive in the hospital. We look forward to continuing to bring this novel technology to more ICUs and Emergency Departments, as well as developing diagnostic and monitoring solutions for additional neurological indications impacting the lives of critically ill patients," Jane Chao, Founder and CEO Ceribell.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.